Covis Pharmaceuticals Inc., of Cary, N.C., said Lanoxin is now offered in four dosage strengths, including 0.0625 mg and 0.1875 mg, for the treatment of mild-to-moderate heart failure in adults, and for the control of ventricular response rate in adult patients with chronic atrial fibrillation.